RenovaCare products are under development and not approved for sale in the United States.
Results may vary from person to person.

 

RENOVACARE
INVESTOR FORUM

Presented on: October 29, 2020

Click Play button on left to view presentation

READ THE FULL
TRANSCRIPT HERE

 

RENOVACARE
INVESTOR FORUM

Presented on: October 29, 2020

Click Play button above to view presentation

READ THE FULL
TRANSCRIPT HERE

Latest Press Releases

RenovaCare Awarded New Patents Allowing Greater Versatility of SkinGun™; Sterility in Field Environments; Spray Solutions to Now Include Targeted Cells, Drugs or Hormones

Roseland, NJ – November 19, 2020 – RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), developer of patented technologies for spraying self-donated stem cells for the regeneration of skin and other organs and tissues, today announced the issuance of two new patents encompassing improvements to the SkinGun™, expanding its potential application beyond the surgical setting into the field, and allowing the use of liquid suspension solutions to include drugs, hormones, and other useful agents.

Read more

RenovaCare to Commence Investor Business and Financial Presentations; Webcast on October 29, 2020

Roseland, NJ – October 5, 2020 – RenovaCare, Inc. (Symbol: RCAR), developer of patented technologies for spraying self-donated stem cells for the regeneration of skin and other organs and tissues, today announced that Alan L. Rubino, Chief Executive Officer and President, has been elected to the additional role of Chairman of the Board of RenovaCare effective October 1, 2020.

Read more

Company Overview

RenovaCare, Inc. is committed to the highest standards of ethical behavior and the Company’s commitment extends to all aspects of its role as an employer and as a corporate citizen. This commitment to ethical behavior extends beyond mere compliance with laws and regulations to inspire our relationships with our shareholders, clients, and employees.

Corporate Office:

RenovaCare, Inc.
4 Becker Farm Road, Suite 105
Roseland, New Jersey 07068
1-888-398-0202

Sign Up for Investor Alerts